NovaVision provides a portfolio of FDA registered diagnostic and therapy products for vision disorders resulting from a stroke or other neurological brain injury. The therapies are evidence-based, supported by decades of scientific research and clinical studies.
Home Test
- Home
- Home Test
ViewSite Brain Access System (VBAS)
ViewSite Brain Access System (VBAS) is a clear cylindrical set of disposable devices of different sizes which neurosurgeons use to provide a surgical corridor to access sites within the brain such as tumors. VBAS allows the surgeon seamless entry to the targeted site while distributing brain tissue evenly in a 360° dispersion pattern.
VBAS benefits include: less invasive procedure; reduction of pressure, reduced tissue damage; superior visualization; improved working channel; more accurate target access; reduced target shift; reduced operating time and hospital stay.
NovaVision
NovaVision has a family of complementary, computer-based diagnostic and therapy for those suffering from vision loss resulting from neurological trauma such as stroke, provided both in a clinical environment and direct to home:
Vision Restoration Therapy (VRT) is a restitution or restoration therapy designed to improve visual sensitivity in the previously blind zones by using light to stimulate the border between the “seeing” and “blind” visual fields.
NeuroEyeCoach is a saccadic training program designed to address a patient’s difficulty with eye movement and integration of visual information. The therapy re-trains the patient’s ability to scan the environment, re-integrate left and right vision and make the most of their remaining visual field. It is intuitive and user friendly for both patient and therapist.
Vision Diagnostic Test (VIDIT) is a high-resolution campimetric test that enables therapist to quickly screen for central visual field deficits in the clinic.